Taal in het Nederlands Language is English
Become a member | Lost your password?
Physicaltherapyscience.com- News - Multicenter study into the effects of long-term physiotherapy rehabilitation in COPD (GOLD (III-IV) on drug therapy and hospitalizations

Multicenter study into the effects of long-term physiotherapy rehabilitation in COPD (GOLD (III-IV) on drug therapy and hospitalizations

01-04-2019
A total of 21 physiotherapy practices in The Netherlands were definitively included by research group from Physical Therapy & Science Association, in the study. They provided retrospectively (2018) research data from 402 patients with severe to very severe COPD (♂ 207, ♀ 193). In 2018, this cohort was offered first-line physiotherapy rehabilitation with an average frequency of twice a week. In 2018, this led to an average of 2.3 exacerbations and 0.4 hospitalizations (duration μ 10.7 days) per year.

The drug therapy for a exacerbation led to prescription of antibiotics (μ 1.6 per year) and prednisolone (μ 1.7 per year). Within the cohort the general practitioner or lung physician prescribed the long-term use of antibiotics (6%) and prednisolone (3%).

This cohort study will be continued in 2019 to investigate the effects of reducing the frequency of physiotherapy rehabilitation on medication use and hospitalizations.


Drs. D. Postel, Mw. drs. S. Werner, Drs. C. Freriks, Mw. Drs. M. Willekens, Dr. N. Hutting, Drs. D.M. Keesenberg
Physical Therapy & Science Association

Physical Therapy Science

COPD

Physical Therapy

News

The effects of reducing the frequency of long-term physiotherapy on patiënts with severe COPD: a Dutch multicenter study

06-07-2022
The Physical Therapy & Science Association (F&W) performed a study on the consequences of reducing the frequency of longterm...

Case report

False negative thoracic x-ray

F&W Case Report 2013; 7: 1
Patient, a man of 58 years old, consult a physiotherapist with complaints of cramp and very severe back pain level T6-T10 and radiating...

Expert opinion

Exercise adherence in chronic obstructive pulmonary disease

F&W Expert Opinion 2024; 2: 1
Introduction Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide, with an economic and...